Navigation Links
Teamwork Unlikely to Improve Cholesterol Levels
Date:3/8/2010

Doctor/pharmacist collaboration made little difference in patient health, study found

MONDAY, March 8 (HealthDay News) -- For patients with high cholesterol, joint physician-pharmacist care to help them manage their lipid levels doesn't have a significant impact, a new study finds.

Canadian researchers looked at partnerships where doctors were responsible for prescribing cholesterol-lowering medications and pharmacists provided counseling, requested laboratory tests, monitored the safety and effectiveness of the treatment and adjusted medication as needed. But there was no evidence that this method of patient care had a significant clinical impact on lipid control, the study found.

"In a primary care collaborative model, where community pharmacists are responsible for providing counseling on lifestyle changes and adjusting lipid-lowering medication, patients had more health-professional visits, more laboratory tests and were more likely to have their lipid-lowering treatment modified and report making lifestyle changes," wrote the researchers. "However, this did not translate into significant clinical impact on lipid control."

The study is published online March 8 in the Canadian Medical Association Journal.

The researchers suggested that future studies should examine the long-term benefits of this type of collaborative care in patients at high risk for coronary heart disease.

More information

The American Heart Association has more about cholesterol.



-- Robert Preidt



SOURCE: Canadian Medical Association Journal, news release, March 8, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Coordinated Teamwork, Planning Futuristically And Acting Now Breed Health, Success
2. Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs
3. Graham Packagings Teamwork with Invitrogen Leads to an Award-Winning New Medical Container
4. Teamwork cuts out unnecessary biopsies, researchers find
5. Virus Unlikely to Cause Chronic Fatigue Syndrome
6. Older dental fillings contain form of mercury unlikely to be toxic
7. 2/3 of Australians unlikely to get vaccinated against swine flu
8. Study Shows Hospital Report Cards Unlikely to Spur Improvement
9. Los Angeles fast-food restaurant ban unlikely to cut obesity, study finds
10. Congress Unlikely to Pass Permanent Medicare Physician Payment Fix in 2009, says MedicareSupplementPlans.com
11. Europe Unlikely to Meet Measles Goals: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... , ... Medical lab testing through hospitals and other traditional methods ... will take days to arrive to the end customer, having to travel through medical ... lab tests, bypassing the cost and delay of traditional means. Now all employees of ...
(Date:1/21/2017)... ... 2017 , ... Salveo for life, a company that distributes an effervescent lime-flavored ... States as part of its presence to expand its market reach. , Using a ... productions of nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Seamild, the ... on the futuristic vision of its owner and founder. As Oat is recognized globally ... to everybody he knows personally as he believes it is a move to sow ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s ... electrifying line-up of events for its annual meeting “Coming Home 2017,” an activity-packed ... “Coming Home 2017” will be held on Friday January 27 through Sunday, January ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa ... in Petaluma, located at 167 Lynch Creek Way. The Petaluma office features three ... medicine and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Therabron Therapeutics, Inc., a clinical-stage ... in respiratory care, today announced that the European ... has granted Orphan Drug Designation for Therabron,s CG367 ... Syndrome (BOS).  "We are pleased to ... to treat patients diagnosed with BOS following lung ...
(Date:1/23/2017)... , Jan. 23, 2017 LifeVac, the ... a blocked airway and prevented choking deaths, welcomes ... advocate to the LifeVac team as Official Spokesperson. ... join the LifeVac team," said Arthur Lih , ... to represent LifeVac and his mission to raise awareness ...
(Date:1/23/2017)... 23, 2017 Research and Markets has announced the ... - Product - Forecast to 2025" report to their offering. ... Report Highlights: ... trends to identify the investment opportunities Market forecasts till ... Key market trends across the business segments, Regions and Countries ...
Breaking Medicine Technology: